Wells Fargo keeps Equal-Weight on Coinbase, Incyte, Alnylam and trims targets
Wells Fargo kept Equal-Weight ratings on Coinbase Global, Incyte and Alnylam Pharmaceuticals but cut price targets on all three, according to TradingView.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Wells Fargo analysts kept Equal-Weight ratings on Coinbase Global, Incyte and Alnylam Pharmaceuticals but lowered their price targets, TradingView reports. The Coinbase Global target fell to $174 from $200, a 13.0% decrease. With the stock closing at $160.59 on October 29, the new target implies an 8.4% upside.
The Incyte target was trimmed to $127 from $128, a 0.8% decrease. The target implies an 8.7% upside from the October 29 close of $116.80. Alnylam Pharmaceuticals received a target of $220, down from $253, a 13.0% decrease. From the October 29 close of $174, that target implies a 26.4% upside.
Across the five most recent analyst notes on Coinbase Global over the past 30 days, targets from other firms range from $120 to $240.
why it matters
Routine target cuts with unchanged ratings usually change little for investors. The market tends to focus more on the reasons behind such revisions and on the upcoming company results.
tags
instruments
sources
- Wells Fargo maintains Coinbase Global at Equal-Weight, lowers price target to $174 from $200 — TradingView, 30 October 2026 at 16:30 UTC
- Wells Fargo maintains Incyte at Equal-Weight, lowers price target to $127 from $128 — TradingView, 30 October 2026 at 16:44 UTC
- Wells Fargo maintains Alnylam Pharmaceuticals at Equal-Weight, lowers price target to $220 from $253 — TradingView, 30 October 2026 at 16:41 UTC
- Wells Fargo maintains NovoCure at Equal-Weight, lowers price target to $15 from $20 — TradingView, 30 October 2026 at 16:52 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗